Supplemental Figure 1

4
Supplemental Figure 1 TR -C 2D TR-C2 TR -C 2N 0 40 80 120 160 SPARC/Osteonectin # TR -C 2D TR-C 2 TR-C 2N 0 40 80 120 160 Control C A-Akt1 DN -Akt1 Fibrone ctin # # # TR -C 2D TR-C2 TR -C 2N 0 40 80 120 160 BSP/Osteopontin * # TR -C2D TR-C2 TR-C 2N 0 40 80 120 160 Lamini n # # # TR -C 2D TR-C2 TR -C 2N 0 40 80 120 160 Vitronec tin # # * # (-) EGF; 12 Hr # C A-Akt1 D N-Akt1 TR- C2 pS 473 Ak t C ontrol C A-A kt1 Cont rol DN-Akt1 C A-Akt1 C ontrol D N-Akt1 TR- C2D TR-C2N β- actin A B C D E F

description

Supplemental Figure 1. CA-Akt1. DN-Akt1. DN-Akt1. CA-Akt1. DN-Akt1. Control. Control. CA-Akt1. Control. A. B. C. (-) EGF; 12 Hr. pS 473 Akt. Migration (% of recovery). Vitronectin. Fibronectin. Laminin. β -actin. #. #. TR-C2D. TR-C2. TR-C2N. #. #. #. #. #. *. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 1

Page 1: Supplemental Figure 1

Supplemental Figure 1

TR-C2D TR-C2 TR-C2N0

40

80

120

160 SPARC/Osteonectin

#

TR-C2D TR-C2 TR-C2N0

40

80

120

160ControlCA-Akt1DN-Akt1

Fibronectin

#

# #

TR-C2D TR-C2 TR-C2N0

40

80

120

160

BSP/Osteopontin

*

#

TR-C2D TR-C2 TR-C2N0

40

80

120

160Laminin

# #

#

TR-C2D TR-C2 TR-C2N0

40

80

120

160Vitronectin

# #

*

#

(-) EGF; 12 Hr

#

CA-A

kt1

DN-A

kt1

TR-C2

pS473Akt

Cont

rol

CA-A

kt1

Cont

rol

DN-A

kt1

CA-A

kt1

Cont

rol

DN-A

kt1

TR-C2D TR-C2N

β-actin

A B C

D E F

Page 2: Supplemental Figure 1

Supplemental Figure 2

CA

-Akt

1 +

WT

β3 in

tegr

in

WT

β3 in

tegr

in

β3 integrin

β-actin

CA

-Akt

1

Con

trol

DN

-Akt

1

DN

-Akt

1 +

WT

β3 in

tegr

in

A B

CA

-Akt

1 +

DN

β3

inte

grin

DN

β3

inte

grin

CA-A

kt1

Cont

rol

β3 integrin

β-actin

Page 3: Supplemental Figure 1

0

25

50

75

10012 Hr24 Hr

#* ## ##

BSP/Osteopontin

WT

β3 in

tegr

in

CA-A

kt1

Cont

rol

DN-A

kt1

CA-A

kt 1

+

WT

β3 in

tegr

inDN

-Akt

1 +

WT

β3 in

tegr

in

C

0

25

50

75

10012 Hr24 Hr

A Vitronectin

WT

β3 in

tegr

in

CA-A

kt1

Cont

rol

DN-A

kt1

CA-A

kt 1

+

WT

β3 in

tegr

inDN

-Akt

1 +

WT

β3 in

tegr

in

#* ## ## ##

0

25

50

75

10012 Hr24 zHr SPARC/Osteonectin

** ## ## ##

WT

β3 in

tegr

in

CA-A

kt1

Cont

rol

DN-A

kt1

DN-A

kt 1

+ W

T β3

inte

grin

CA-A

kt 1

+

WT

β3 in

tegr

in

B Supplemental Figure 3

Page 4: Supplemental Figure 1

0.0 0.5 1.0 1.5 2.00.6

0.7

0.8

0.9

1.0

1.1ComtrolCA-Akt1Comtrol+WT 3b integrinCA-Akt1+WT 3b integrin

C

0.0 0.5 1.0 1.5 2.00.6

0.7

0.8

0.9

1.0

1.1ControlDN-Akt1Control+WT b3 integrinDN-Akt1+WT b3 integrin

0.7

0.8

0.9

1.0

1.1

Time (h)

Time (h)

0.7

0.8

0.9

1.0

1.1

D

# #

#

#

CA-A

kt1

+ W

T β3

inte

grin

WT

β3

inte

grin

CA-A

kt1

Cont

rol

WT

β3in

tegr

in

Cont

rol

DN-A

kt1

DN-A

kt1

+ W

T β3

inte

grin

A B Supplemental Figure 4